184 open real-world evidence positions
Merck & Co.
Tempus
AstraZeneca
Novartis
Edwards Lifesciences
Sanofi
BeOne Medicines
BeiGene
Fortrea
Neurocrine Biosciences
Bristol Myers Squibb
Abbott